AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $31.26 Per Share, $10.1 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Immunogen (IMGN) shares surge on news of takeover by AbbVie (ABBV)
November 30, 2023 9:09 AM ESTAbbVie (NYSE: ABBV) announced Thursday that it will acquire Immunogen (NASDAQ: IMGN) and its flagship cancer therapy, Elahere, in a deal worth $31.26 per share.
The transaction values ImmunoGen at a total equity value of approximately $10.1 billion and is expected to close in the middle of 2024.
Elahere... More
Sutro Biopharma (STRO) Trades Higher in Sympathy with Immunogen (IMGN)
November 30, 2023 7:45 AM ESTSutro Biopharma Inc. (NASDAQ: STRO) Trades Higher in Sympathy with Immunogen (NASDAQ: IMGN)
Earlier:
AbbVie Inc. (NYSE: ABBV) and ImmunoGen, Inc. (NASDAQ: IMGN) today announced a definitive agreement under which AbbVie will... MoreImmunogen (IMGN) to Resume Trading at 8 a.m. Following News of Takeover by AbbVie (ABBV)
November 30, 2023 7:41 AM ESTImmunogen (NASDAQ: IMGN) to Resume Trading at 8 a.m. Following News of Takeover by AbbVie (NYSE: ABBV)
Earlier:
AbbVie Inc. (NYSE:... More